Biosyntia
Company

Last deal

$10.4M
Local Amount - EUR 11.5M

Amount

Series B

Stage

06.07.2022

Date

3

all rounds

$15.9M

Total amount

General

About Company
Biosyntia is a biotech startup that develops bio-catalysts for the production of complex chemical compounds by fermentation.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2012

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

The company's patent-pending high-throughput screening technology enables the development of tailored processes based on biocatalysis, which can substantially reduce production costs and environmental impact. Biosyntia partners with manufacturers of fine chemical compounds to establish more sustainable manufacturing processes for a greener tomorrow.
Contacts

Social url